9,646 reports of this reaction
10.8% of all HYDROCODONE BITARTRATE reports
#3 most reported adverse reaction
OVERDOSE is the #3 most commonly reported adverse reaction for HYDROCODONE BITARTRATE, manufactured by Purdue Pharma LP. There are 9,646 FDA adverse event reports linking HYDROCODONE BITARTRATE to OVERDOSE. This represents approximately 10.8% of all 89,079 adverse event reports for this drug.
Patients taking HYDROCODONE BITARTRATE who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is a frequently reported adverse event for HYDROCODONE BITARTRATE, accounting for a significant proportion of all reports.
In addition to overdose, the following adverse reactions have been reported for HYDROCODONE BITARTRATE:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 9,646 FDA reports for HYDROCODONE BITARTRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 10.8% of all adverse event reports for HYDROCODONE BITARTRATE, making it one of the most commonly reported side effect.
If you experience overdose while taking HYDROCODONE BITARTRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.